Mainz Biomed (MYNZ) said Friday it is implementing a one-for-40 reverse stock split of its common stock, effective Dec. 3, following the board's decision on Nov. 20.
No fractional shares will be issued. Instead, Mainz Biomed will pay cash depending on the value of the fractional shares, the company said.
The company's shares were down more than 12% in recent premarket trading.
Price: 0.22, Change: -0.032, Percent Change: -12.50
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments